What Are the Ozempic Doses for Weight Loss?

Last reviewed: June 29, 2026

Last updated: June 29, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist originally developed for type 2 diabetes that has become a leading medication for chronic weight management. The medication works by slowing stomach emptying, increasing feelings of fullness, and reducing appetite signals in the brain. Weight loss treatment with semaglutide follows a structured titration schedule designed to help your body adapt while achieving sustainable results.

How Semaglutide Dosing Works for Weight Loss

Semaglutide weight loss treatment does not use a one-size-fits-all approach. Instead, patients begin at the lowest effective dose and gradually increase over several weeks based on individual tolerance and clinical response. This gradual titration—called a dose escalation protocol—allows your body to adjust to the medication while minimizing gastrointestinal side effects like nausea and constipation. Your healthcare provider monitors your progress and adjusts your dose during follow-up visits to ensure you reach your optimal therapeutic level.

Most weight loss programs using semaglutide follow a standard four-week escalation schedule, though the timeline can be adjusted based on your medical history, kidney function, and side effect tolerance. Starting at the lowest dose reduces the risk of adverse reactions while still providing meaningful appetite suppression and metabolic benefits. The goal is to find your effective maintenance dose—the level where you experience good weight loss results with manageable side effects you can sustain long-term.

Typical Semaglutide Injection Starting Dose and Escalation Schedule

Weight loss treatment with semaglutide typically begins at 0.25 mg injected subcutaneously once per week. This introductory dose is below the diabetes dosing range and is specifically designed for weight management in patients without type 2 diabetes. During week one through week four, you remain at the 0.25 mg dose while your body adapts to the medication. Most patients tolerate this initial dose well, experiencing mild appetite reduction without severe nausea or digestive changes.

In weeks five through eight, your dose increases to 0.5 mg weekly. This step-up continues to improve appetite suppression while allowing your gastrointestinal system to gradually accommodate the higher drug concentration. Many patients report noticeable weight loss beginning in this phase, with typical losses ranging from two to four pounds per week on average. If you tolerate 0.5 mg without significant side effects, your provider may continue escalation during weeks nine through twelve to 1.0 mg weekly, where many patients reach their therapeutic sweet spot for sustained weight loss.

Maximum Effective Doses and Maintenance Therapy

For chronic weight management, semaglutide doses can increase further to 1.7 mg or 2.4 mg weekly, depending on your clinical response and tolerance. However, not every patient requires or benefits from the highest available doses. Some achieve excellent weight loss results and maintain them at 0.5 mg or 1.0 mg weekly, while others need higher doses to overcome genetic predispositions toward weight gain. Your ideal maintenance dose is the lowest effective dose that produces consistent weight loss while remaining tolerable for your lifestyle.

Once you reach a dose where you're experiencing meaningful results with manageable side effects, that becomes your maintenance dose. You continue that same weekly injection indefinitely as long as treatment goals are being met. If weight loss plateaus after several months at your current dose, your provider may recommend a modest increase. Conversely, if side effects become problematic, a temporary dose reduction followed by slower re-escalation can help you find better balance between efficacy and tolerability.

Personalized Semaglutide Dosing with PlexusDx Genetic Testing

The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Patients with certain genetic profiles may achieve target weight loss at lower doses, while others may benefit from faster escalation to higher maintenance doses. The Precision Peptide test costs only $298, giving you and your provider over 150 personalized genetic insights. This precision approach transforms weight loss from guesswork into a science-backed strategy aligned with your unique biology. PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan, ensuring you receive personalized care without premium pricing.

Side Effects During Dose Escalation and How to Manage Them

Common side effects during the early weeks of semaglutide treatment include mild nausea, constipation, fatigue, and loss of appetite. These effects typically peak two to three days after injection and gradually improve over the following days as your body adjusts. Slower dose escalation—spreading increases over six to eight weeks instead of four weeks—significantly reduces the severity of nausea and gastrointestinal upset. Staying well-hydrated, eating smaller frequent meals, and avoiding fatty or greasy foods can further minimize discomfort during dose adjustments.

Most side effects resolve within two to four weeks at any given dose level. However, if severe nausea, vomiting, or persistent constipation develops, contact your PlexusDx provider immediately—you may benefit from pausing your dose escalation or temporarily reducing your dose. Serious side effects are rare but can include severe dehydration, acute kidney injury (especially if you have existing kidney disease), and pancreatitis symptoms like severe upper abdominal pain. Your PlexusDx provider screens for contraindications and monitors your kidney function and overall health to ensure safe, effective treatment at every dose milestone.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

What is the starting dose of semaglutide for weight loss?

Semaglutide weight loss treatment begins at 0.25 mg injected under the skin once weekly. This low starting dose minimizes nausea and allows your body to adapt before escalating every four weeks to higher doses. PlexusDx provides personalized dosing guidance with your compounded semaglutide injection, which starts at just $189/mo (or $149/mo on the 6-month plan) regardless of dose level.

How quickly does semaglutide dosing increase?

A standard escalation schedule increases your dose every four weeks: starting at 0.25 mg, then moving to 0.5 mg, 1.0 mg, 1.7 mg, and potentially 2.4 mg. However, your PlexusDx provider can adjust this timeline based on your tolerance and side effects. Slower escalation over six to eight weeks is often better tolerated, especially if you experience nausea.

Will my semaglutide price increase if my dose goes up?

No. PlexusDx pricing is flat regardless of dose escalation. Your semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan), and that price remains the same whether you're at 0.25 mg or 2.4 mg. Your dose may need to go up. Your price won't.

What dose of semaglutide produces the most weight loss?

Higher doses generally produce more weight loss, but the relationship is not linear. Many patients achieve excellent sustained weight loss at 1.0 or 1.7 mg weekly. Doses of 2.4 mg produce the most weight loss in clinical trials—averaging 17% body weight reduction over 68 weeks—but carry slightly higher side effect rates. Your optimal dose is the lowest one that produces meaningful results with tolerable side effects.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Weight Loss Drugs Like Ozempic
• Ozempic Weight Loss Before And After Pictures

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.